Kaushik Pankhuri, Mishra Radha, Gopal Champaka, Kumar Arun
Department of Developmental Biology and Genetics, Indian Institute of Science, Bangalore, India.
Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India.
Front Oncol. 2024 Dec 4;14:1485802. doi: 10.3389/fonc.2024.1485802. eCollection 2024.
miRNAs play a critical role in the progression of various diseases, including oral squamous cell carcinoma (OSCC), which represents a major health concern and is one of the leading causes for new cancer cases worldwide. The miRNA dysregulation causes havoc and could be attributed to various factors, with epigenetic silencing of tumor suppressor genes being a major contributor to tumorigenesis. In this study, we have explored the tumor suppressive role of miR-198 in OSCC.
The tumor suppressive effect of miR-198 is established using miRNA analysis in OSCC cell lines, patient samples and xenograft nude mice model. The relationship between the miR-198 and is explored using bioinformatics analyses, qRT-PCR, dual-luciferase reporter assay, Western blotting and cancer hall marks assays. The hypermethylation of the promoter is confirmed using bisulfite sequencing PCR.
We have found miR-198 to be upregulated in OSCC cells treated with 5-Azacytidine, a known DNA methyltransferase inhibitor. Upregulation of miR-198 in 5-Azacytidine treated OSCC cells appears to be due to methylation of the promoter. Using bioinformatics analysis and dual-luciferase reporter assay, we have identified (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase) as a novel gene target for miR-198. miR-198-mediated repression of TOPORS decreases cell proliferation and anchorage-independent growth and enhances apoptosis of OSCC cells, which is dependent on the presence of the 3'UTR in . An inverse correlation between the expression levels of miR-198 and is observed in OSCC patient samples, highlighting the biological relevance of their interaction. Delivery of a synthetic miR-198 mimic to OSCC cells results in a significant decrease in xenograft size in nude mice, potentiating its use in therapeutics.
These results suggest that miR-198 is epigenetically silenced in OSCC, which promotes tumor growth, in part, by upregulating the levels of .
微小RNA(miRNA)在包括口腔鳞状细胞癌(OSCC)在内的多种疾病进展中起关键作用,OSCC是一个重大的健康问题,也是全球新癌症病例的主要原因之一。miRNA失调会造成严重破坏,可能归因于多种因素,其中肿瘤抑制基因的表观遗传沉默是肿瘤发生的主要因素。在本研究中,我们探讨了miR-198在OSCC中的肿瘤抑制作用。
通过对OSCC细胞系、患者样本和异种移植裸鼠模型进行miRNA分析,确定miR-198的肿瘤抑制作用。使用生物信息学分析、定量逆转录聚合酶链反应(qRT-PCR)、双荧光素酶报告基因检测、蛋白质免疫印迹法和癌症特征检测,探讨miR-198与[具体基因名称未给出]之间的关系。使用亚硫酸氢盐测序PCR确认[具体基因名称未给出]启动子的高甲基化。
我们发现,在用已知的DNA甲基转移酶抑制剂5-氮杂胞苷处理的OSCC细胞中,miR-198上调。5-氮杂胞苷处理的OSCC细胞中miR-198的上调似乎是由于[具体基因名称未给出]启动子的甲基化。通过生物信息学分析和双荧光素酶报告基因检测,我们确定[TOP1结合精氨酸/丝氨酸丰富蛋白,E3泛素连接酶,即TOPORS]为miR-198的一个新基因靶点。miR-198介导的TOPORS抑制可降低细胞增殖和非锚定依赖性生长,并增强OSCC细胞的凋亡,这取决于TOPORS中3'非翻译区(3'UTR)的存在。在OSCC患者样本中观察到miR-198和TOPORS表达水平呈负相关,突出了它们相互作用的生物学相关性。将合成的miR-198模拟物导入OSCC细胞会导致裸鼠体内异种移植瘤大小显著减小,增强了其在治疗中的应用潜力。
这些结果表明,miR-198在OSCC中发生表观遗传沉默,这部分通过上调[TOPORS]水平促进肿瘤生长。